Imperial College London

ProfessorHectorKeun

Faculty of MedicineDepartment of Surgery & Cancer

Professor of Biochemistry
 
 
 
//

Contact

 

+44 (0)20 7594 3161h.keun

 
 
//

Location

 

officesInstitute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Sood:2017:10.1038/bjc.2016.432,
author = {Sood, D and Johnson, N and Jain, P and Siskos, AP and Bennett, M and Gilham, C and Busana, MC and Peto, J and dos-Santos-Silva, I and Keun, HC and Fletcher, O},
doi = {10.1038/bjc.2016.432},
journal = {British Journal of Cancer},
pages = {382--388},
title = {CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites},
url = {http://dx.doi.org/10.1038/bjc.2016.432},
volume = {116},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - background: Endogenous sex hormones are well-established risk factors for breast cancer; the contribution of specific oestrogen metabolites (EMs) and/or ratios of specific EMs is less clear. We have previously identified a CYP3A71C allele that is associated with lower urinary oestrone (E1) levels in premenopausal women. The purpose of this analysis was to determine whether this allele was associated with specific pathway EMs.methods: We measured successfully 12 EMs in mid-follicular phase urine samples from 30 CYP3A71C carriers and 30 non-carriers using HPLC-MS/MS.results: In addition to having lower urinary E1 levels, CYP3A71C carriers had significantly lower levels of four of the 2-hydroxylation pathway EMs that we measured (2-hydroxyestrone, P=1.1 × 10−12; 2-hydroxyestradiol, P=2.7 × 10−7; 2-methoxyestrone, P=1.9 × 10−12; and 2-methoxyestradiol, P=0.0009). By contrast, 16α-hydroxylation pathway EMs were slightly higher in carriers and significantly so for 17-epiestriol (P=0.002).conclusions: The CYP3A71C allele is associated with a lower urinary E1 levels, a more pronounced reduction in 2-hydroxylation pathway EMs and a lower ratio of 2-hydroxylation:16α-hydroxylation EMs in premenopausal women. To further characterise the association between parent oestrogens, EMs and subsequent risk of breast cancer, characterisation of additional genetic variants that influence oestrogen metabolism and large prospective studies of a broad spectrum of EMs will be required.
AU - Sood,D
AU - Johnson,N
AU - Jain,P
AU - Siskos,AP
AU - Bennett,M
AU - Gilham,C
AU - Busana,MC
AU - Peto,J
AU - dos-Santos-Silva,I
AU - Keun,HC
AU - Fletcher,O
DO - 10.1038/bjc.2016.432
EP - 388
PY - 2017///
SN - 1532-1827
SP - 382
TI - CYP3A71C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites
T2 - British Journal of Cancer
UR - http://dx.doi.org/10.1038/bjc.2016.432
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394445400018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/45320
VL - 116
ER -